Antibiotics Inhibiting Protein Synthesis
Uploaded by
Abdelrahman KhaledAntibiotics Inhibiting Protein Synthesis
Uploaded by
Abdelrahman KhaledCommon questions
Powered by AILow doses of erythromycin and lincomycin stimulate the dissociation of erroneous peptidyl-tRNAs. This specific action suggests that these antibiotics may play a role in reducing the synthesis of malfunctioning proteins, diminishing bacterial resistance or fitness by eliminating the erroneous polypeptides before they contribute to cellular functions .
Peptidyl-tRNA hydrolase in E. coli catalyzes the hydrolysis of peptidyl-tRNA that dissociates from the ribosome during protein synthesis. If the enzyme is dysfunctional, as in mutant pthts E. coli at nonpermissive temperatures, the accumulation of peptidyl-tRNA inhibits protein synthesis, leading to cell death. This accumulation suggests that continuous protein synthesis is essential for cell survival and growth .
Macrolides and lincosamides enhance the dissociation of peptidyl-tRNA from the ribosome, increasing the incidence of incomplete peptides during protein synthesis. This mechanism suggests a primary mode of action that interrupts protein elongation leading to the accumulation of erroneous proteins or nonfunctional peptides, undermining bacterial viability .
Erythromycin, while managing translational errors by promoting erroneous peptidyl-tRNA dissociation, cannot counteract post-translational errors induced by canavanine, an arginine analogue. Canavanine enhances errors in protein folding and function at a post-translational level which erythromycin does not address, highlighting its specificity to translational mechanisms .
Protein synthesis inhibitors typically target the differences in ribosome structure between prokaryotic and eukaryotic cells. Prokaryotic ribosomes have a distinct structure which allows these inhibitors to specifically bind and interfere with protein synthesis processes unique to prokaryotes, minimizing effects on eukaryotic ribosomes and thus reducing toxicity in human cells .
Chloramphenicol prevents cell death in temperature-sensitive E. coli by blocking the accumulation of peptidyl-tRNA, stabilizing the ribosomal complex, and thus allowing protein synthesis to continue. On the other hand, erythromycin enhances cell death by promoting the dissociation of peptidyl-tRNA from the ribosome, leading to impaired protein synthesis and increased cell mortality .
Chloramphenicol is primarily effective at inhibiting the peptidyltransferase activity associated with the 50S ribosomal subunit of bacteria, thereby inhibiting protein elongation. It does not affect post-translational modification processes as its primary target is the translation stage of protein synthesis, rather than modifications occurring after a polypeptide chain has been synthesized .
The study of erroneous peptidyl-tRNAs provides insight into how some antibiotics can selectively hinder bacterial protein synthesis by facilitating the dissociation of incomplete or incorrect polypeptides. This not only decreases bacterial fitness by disrupting cellular processes dependent on functional proteins but also accentuates the antibiotics' potential to reduce translational fidelity, providing a selective advantage in addressing bacterial infections .
Temperature-sensitive E. coli mutants serve as a model to study the dynamics of peptidyl-tRNA and the effect of different antibiotics on protein synthesis. By observing the specific blocking or enhancement of peptidyl-tRNA accumulation at nonpermissive temperatures, researchers can gain insights into the distinct mechanisms of antibiotics such as chloramphenicol and erythromycin, further elucidating their roles in preventing or exacerbating cellular stress and death .
Erythromycin preferentially stimulates the dissociation of erroneous peptidyl-tRNAs, thereby reducing the incorporation of these errors into proteins. When E. coli cells are stressed by amino acid starvation, erythromycin reduces the shortened time to inactivate beta-galactosidase, demonstrating its ability to preferentially clear erroneous substrates and thereby indirectly maintain a higher level of protein integrity .